Lazard is acting as the exclusive financial advisor to Collegium. Hogan Lovells is serving as M&A legal counsel to Collegium. Goodwin Procter LLP is serving as...
Collegium Pharmaceutical’s $525 Million Acquisition Of Ironshore Therapeutics
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
Synopsys’ Acquisition of ANSYS
Cleary Gottlieb Steen & Hamilton is representing Synopsys, while Skadden and Goodwin Procter are representing ANSYS on the deal. Synopsys, Inc. (Synopsys) announced its acquisition of...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
AstraZeneca’s $1.1 Billion Acquisition of Icosavax
Centerview Partners LLC is serving as exclusive financial advisor to Icosavax and Goodwin is serving as legal counsel. Icosavax, Inc. (Nasdaq: ICVX) announced it has entered...
Generate:Biomedicines’ $273 Million Series C Funding Round
Goodwin advised Generate:Biomedicines on the fundraising. Generate:Biomedicines announced that it has raised $273 million in Series C financing. This financing round attracted many new investors including...
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Evelo Biosciences’ $25.5 Million Private Placement
Goodwin advised Flagship Pioneering on the investment. Evelo Biosciences, Inc. (Nasdaq:EVLO) announced a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of...
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
Moderna’s Collaboration with Generation Bio
Goodwin advised Moderna, Inc. on the deal. Moderna, Inc. (Nasdaq:MRNA) announced its strategic collaboration with Generation Bio Co. (Nasdaq:GBIO) to combine Moderna’s biological and technical expertise with...
Symphony Technology Group’s $1.5 Billion Acquisition of Momentive
Goodwin Procter advised Qatalyst Partners on the deal. Qatalyst Partners acted as financial advisor to Momentive (Nasdaq: MNTV) in a definitive agreement to be acquired by a...
Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.
Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....